Real-life Effectiveness and Safety of Guselkumab in Moderate-to-Severe Plaque Psoriasis: A 104-Week Retrospective Single-Center Study.

Luigi GargiuloLuciano IbbaAndrea CorteseFrancesco TosoCarlo A VignoliGiovanni FiorilloFrancesco PiscazziMario ValentiAntonio CostanzoAlessandra Narcisi

Published in: Journal of drugs in dermatology : JDD (2024)

Our findings, although limited by the study's retrospective nature, confirm that guselkumab is a safe and effective therapeutic option for a "real-life" cohort of patients with psoriasis. J Drugs Dermatol. 2024;23(8):632-639.  doi:10.36849/JDD.7486R1.

Keyphrases

cross sectional
coronary artery disease
high intensity
atopic dermatitis
randomized controlled trial
clinical trial